IBDEI062 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14725,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,14725,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,14725,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,14726,0)
 ;;=Q61.2^^62^695^86
 ;;^UTILITY(U,$J,358.3,14726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14726,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,14726,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,14726,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,14727,0)
 ;;=N41.1^^62^695^90
 ;;^UTILITY(U,$J,358.3,14727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14727,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,14727,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,14727,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,14728,0)
 ;;=N11.9^^62^695^98
 ;;^UTILITY(U,$J,358.3,14728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14728,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,14728,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,14728,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,14729,0)
 ;;=N20.9^^62^695^116
 ;;^UTILITY(U,$J,358.3,14729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14729,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,14729,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,14729,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,14730,0)
 ;;=R97.20^^62^695^29
 ;;^UTILITY(U,$J,358.3,14730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14730,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,14730,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,14730,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,14731,0)
 ;;=N52.36^^62^695^34
 ;;^UTILITY(U,$J,358.3,14731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14731,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,14731,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,14731,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,14732,0)
 ;;=N52.37^^62^695^35
 ;;^UTILITY(U,$J,358.3,14732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14732,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,14732,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,14732,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,14733,0)
 ;;=N52.35^^62^695^36
 ;;^UTILITY(U,$J,358.3,14733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14733,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,14733,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,14733,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,14734,0)
 ;;=R31.21^^62^695^56
 ;;^UTILITY(U,$J,358.3,14734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14734,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,14734,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,14734,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,14735,0)
 ;;=R31.29^^62^695^57
 ;;^UTILITY(U,$J,358.3,14735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14735,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,14735,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,14735,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,14736,0)
 ;;=R39.198^^62^695^70
 ;;^UTILITY(U,$J,358.3,14736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14736,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,14736,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,14736,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,14737,0)
 ;;=R39.191^^62^695^72
 ;;^UTILITY(U,$J,358.3,14737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14737,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,14737,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,14737,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,14738,0)
 ;;=R39.192^^62^695^71
 ;;^UTILITY(U,$J,358.3,14738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14738,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,14738,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,14738,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,14739,0)
 ;;=R97.21^^62^695^101
 ;;^UTILITY(U,$J,358.3,14739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14739,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,14739,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,14739,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,14740,0)
 ;;=N50.82^^62^695^102
 ;;^UTILITY(U,$J,358.3,14740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14740,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,14740,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,14740,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,14741,0)
 ;;=N50.812^^62^695^106
 ;;^UTILITY(U,$J,358.3,14741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14741,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,14741,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,14741,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,14742,0)
 ;;=N50.811^^62^695^107
 ;;^UTILITY(U,$J,358.3,14742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14742,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,14742,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,14742,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,14743,0)
 ;;=N35.919^^62^695^112
 ;;^UTILITY(U,$J,358.3,14743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14743,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,14743,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,14743,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,14744,0)
 ;;=N35.92^^62^695^111
 ;;^UTILITY(U,$J,358.3,14744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14744,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,14744,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,14744,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,14745,0)
 ;;=R82.81^^62^695^99
 ;;^UTILITY(U,$J,358.3,14745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14745,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,14745,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,14745,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,14746,0)
 ;;=R51.^^62^696^2
 ;;^UTILITY(U,$J,358.3,14746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14746,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,14746,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,14746,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,14747,0)
 ;;=G44.1^^62^696^9
 ;;^UTILITY(U,$J,358.3,14747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14747,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,14747,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,14747,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,14748,0)
 ;;=G43.909^^62^696^5
 ;;^UTILITY(U,$J,358.3,14748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14748,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,14748,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,14748,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,14749,0)
 ;;=G44.009^^62^696^1
 ;;^UTILITY(U,$J,358.3,14749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14749,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,14749,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,14749,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,14750,0)
 ;;=G44.40^^62^696^4
 ;;^UTILITY(U,$J,358.3,14750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14750,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,14750,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,14750,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,14751,0)
 ;;=G44.89^^62^696^3
 ;;^UTILITY(U,$J,358.3,14751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14751,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,14751,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,14751,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,14752,0)
 ;;=G44.84^^62^696^7
 ;;^UTILITY(U,$J,358.3,14752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14752,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,14752,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,14752,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,14753,0)
 ;;=G44.301^^62^696^6
 ;;^UTILITY(U,$J,358.3,14753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14753,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,14753,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,14753,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,14754,0)
 ;;=G44.209^^62^696^8
 ;;^UTILITY(U,$J,358.3,14754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14754,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,14754,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,14754,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,14755,0)
 ;;=I30.0^^62^697^5
 ;;^UTILITY(U,$J,358.3,14755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14755,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,14755,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,14755,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,14756,0)
 ;;=I34.8^^62^697^6
 ;;^UTILITY(U,$J,358.3,14756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14756,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,14756,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,14756,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,14757,0)
 ;;=I34.0^^62^697^13
 ;;^UTILITY(U,$J,358.3,14757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14757,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,14757,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,14757,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,14758,0)
 ;;=I34.9^^62^697^12
 ;;^UTILITY(U,$J,358.3,14758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14758,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,14758,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,14758,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,14759,0)
 ;;=I34.2^^62^697^7
 ;;^UTILITY(U,$J,358.3,14759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14759,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,14759,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,14759,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,14760,0)
 ;;=I35.0^^62^697^10
 ;;^UTILITY(U,$J,358.3,14760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14760,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,14760,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,14760,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,14761,0)
 ;;=I35.1^^62^697^9
 ;;^UTILITY(U,$J,358.3,14761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14761,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,14761,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,14761,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,14762,0)
 ;;=I35.2^^62^697^11
 ;;^UTILITY(U,$J,358.3,14762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14762,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,14762,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,14762,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,14763,0)
 ;;=I35.9^^62^697^8
 ;;^UTILITY(U,$J,358.3,14763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14763,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,14763,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,14763,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,14764,0)
 ;;=I38.^^62^697^4
 ;;^UTILITY(U,$J,358.3,14764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14764,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,14764,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,14764,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,14765,0)
 ;;=I05.0^^62^697^18
 ;;^UTILITY(U,$J,358.3,14765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14765,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,14765,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,14765,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,14766,0)
 ;;=I05.8^^62^697^19
 ;;^UTILITY(U,$J,358.3,14766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14766,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,14766,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,14766,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,14767,0)
 ;;=I05.9^^62^697^20
 ;;^UTILITY(U,$J,358.3,14767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14767,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,14767,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,14767,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,14768,0)
 ;;=I07.1^^62^697^21
 ;;^UTILITY(U,$J,358.3,14768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14768,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,14768,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,14768,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,14769,0)
 ;;=I07.9^^62^697^22
 ;;^UTILITY(U,$J,358.3,14769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14769,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,14769,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,14769,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,14770,0)
 ;;=I08.0^^62^697^16
 ;;^UTILITY(U,$J,358.3,14770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14770,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,14770,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,14770,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,14771,0)
 ;;=I09.89^^62^697^17
 ;;^UTILITY(U,$J,358.3,14771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14771,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,14771,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,14771,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,14772,0)
 ;;=I47.1^^62^697^24
 ;;^UTILITY(U,$J,358.3,14772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14772,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,14772,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,14772,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,14773,0)
 ;;=I48.0^^62^697^15
 ;;^UTILITY(U,$J,358.3,14773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14773,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,14773,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,14773,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,14774,0)
 ;;=I49.5^^62^697^23
 ;;^UTILITY(U,$J,358.3,14774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14774,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,14774,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,14774,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,14775,0)
 ;;=I49.8^^62^697^3
 ;;^UTILITY(U,$J,358.3,14775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14775,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,14775,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,14775,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,14776,0)
 ;;=I49.9^^62^697^2
 ;;^UTILITY(U,$J,358.3,14776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14776,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,14776,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,14776,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,14777,0)
 ;;=R00.1^^62^697^1
 ;;^UTILITY(U,$J,358.3,14777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14777,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,14777,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,14777,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,14778,0)
 ;;=I34.1^^62^697^14
 ;;^UTILITY(U,$J,358.3,14778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14778,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,14778,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,14778,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,14779,0)
 ;;=D68.4^^62^698^1
 ;;^UTILITY(U,$J,358.3,14779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14779,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,14779,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,14779,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,14780,0)
 ;;=D59.9^^62^698^2
 ;;^UTILITY(U,$J,358.3,14780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14780,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,14780,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,14780,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,14781,0)
 ;;=C91.00^^62^698^5
 ;;^UTILITY(U,$J,358.3,14781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14781,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,14781,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,14781,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,14782,0)
 ;;=C91.01^^62^698^4
 ;;^UTILITY(U,$J,358.3,14782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14782,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,14782,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,14782,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,14783,0)
 ;;=C92.01^^62^698^7
 ;;^UTILITY(U,$J,358.3,14783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14783,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,14783,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,14783,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,14784,0)
 ;;=C92.00^^62^698^8
 ;;^UTILITY(U,$J,358.3,14784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14784,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,14784,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,14784,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,14785,0)
 ;;=C92.61^^62^698^9
 ;;^UTILITY(U,$J,358.3,14785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14785,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,14785,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,14785,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,14786,0)
 ;;=C92.60^^62^698^10
 ;;^UTILITY(U,$J,358.3,14786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14786,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,14786,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,14786,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,14787,0)
 ;;=C92.A1^^62^698^11
 ;;^UTILITY(U,$J,358.3,14787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14787,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,14787,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,14787,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,14788,0)
 ;;=C92.A0^^62^698^12
 ;;^UTILITY(U,$J,358.3,14788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14788,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,14788,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,14788,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,14789,0)
 ;;=C92.51^^62^698^13
 ;;^UTILITY(U,$J,358.3,14789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14789,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,14789,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,14789,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,14790,0)
 ;;=C92.50^^62^698^14
 ;;^UTILITY(U,$J,358.3,14790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14790,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,14790,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,14790,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,14791,0)
 ;;=C94.40^^62^698^17
 ;;^UTILITY(U,$J,358.3,14791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14791,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,14791,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,14791,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,14792,0)
 ;;=C94.42^^62^698^15
 ;;^UTILITY(U,$J,358.3,14792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14792,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,14792,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,14792,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,14793,0)
 ;;=C94.41^^62^698^16
 ;;^UTILITY(U,$J,358.3,14793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14793,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
